Qisda announced its consolidated revenue for March 2025, showing a month-on-month increase of 13.8% and a year-on-year growth of 6.1%. According to the company, among all its business segments, the medical division posted the strongest growth, followed by the information technology, industrial and commercial solutions, and smart solutions segments, all of which also outperformed the same period last year.
In March 2025, Qisda recorded consolidated revenue of NT$17.679 billion, marking a 6.1% increase compared to the same month last year and a 13.8% rise from the previous month. Cumulatively, revenue for the first quarter (January to March) reached NT$49.8 billion, representing a 6% year-on-year growth.
Qisda highlighted that among its various business segments, the medical division demonstrated the highest growth rate, with the information technology, industrial and commercial, and smart solutions businesses also posting year-on-year increases.
Chairman Peter Chen previously noted that 2025 marks a fresh start for Qisda and maintained an optimistic outlook on the company’s visibility, suggesting that revenue may continue to climb steadily quarter by quarter.
Regarding prospects for Qisda’s four major business groups this year, Chen believes the medical division will maintain double-digit growth and continue to be the company’s strongest growth driver. The smart solutions segment, which saw a slight decline in performance last year due to subsidiary inventory write-downs, is expected to stabilize this year. Although the networking division struggled last year due to client inventory clearance, it appears to have bottomed out and is also anticipated to recover.
As for Qisda’s largest business segment—display products—Chen stated that the recovery trend is clear, with a projected 10% growth this year. Projectors, which hit bottom last year, are also expected to benefit from a similar rebound. Overall, Qisda expects all four major divisions—medical, networking, AIoT, and information and communications—to achieve both higher revenue and profit in 2025 compared to the previous year.
Resource: 佳世達醫療事業帶動營收 3月月增13.8%
